Release Date: 09/12/10 10:19 Summary: Market Update - Further Litigation Price Sensitive: Yes Download Document 81.73KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%